Abstract
Abstract
Purpose
To assess the role of diffusion tensor imaging in assessing liver and splenic parenchymal infiltration in Gaucher’s disease (G.D.) type I and III before and after therapy.
Methods
A prospective study was conducted upon 28 consecutive patients with G.D. type I and III and 28 age and sex-matched controls. They underwent an MRI and DTI of the liver and spleen. Mean diffusivity (M.D.) and fractional anisotropy (F.A.) values of the liver and spleen were evaluated before and after treatment and compared with control.
Results
There was a statistically significant difference in the M.D. value of the liver and spleen between untreated patients and controls and between control and treated patients and in the M.D. value of the liver and spleen between untreated and treated patients. There is a statistically significant difference in the F.A. value of the liver and spleen between untreated patients and controls and in the F.A. value of the liver and spleen between untreated and treated patients. Hemoglobin level was positively correlated with the M.D. value of the spleen. Clinical score was negatively correlated with M.D. value of the spleen and was positively correlated with F.A. values of the liver and F.A. values of the spleen. Spleen volume was negatively correlated with M.D. values of the spleen.
Conclusion
Significant difference in M.D. and F.A. values of liver and splenic parenchyma in p
atients with type I and III G.D. and controls, and between untreated and treated patients. The M.D. and F.A. values were well correlated with some biomarkers of disease activity.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference23 articles.
1. J. Stirnemann, et al. (2017). A review of Gaucher disease pathophysiology, clinical presentation, and treatments. Int. J. Mol. Sci. 18 (2).
2. H.N. Baris, I.J. Cohen, P.K. Mistry (2014). Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history. Pediatr. Endocrinol. Rev. 12 (Suppl. 1) 72–81.
3. Katz R, Booth T, Hargunani R, et al (2011). Radiological aspects of Gaucher disease. Skeletal Radiol 40:1505–13.
4. Vom Dahl S, Poll L, Di Rocco M, et al (2006). Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 22:1045–64.
5. Roca M, Mota J, Alfonso P, et al (2007). S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease. Eur J Radiol 62:132-7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献